drugset / Trial / NCT04208958
Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
This study evaluated the safety and efficacy of VE800 in combination with nivolumab in patients with selected types of advanced or metastatic cancer
Timeline
- Start
- 2020-01-23
- Primary completion
- 2021-08-26
- Completion
- 2023-02-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VE800 | Other / unclassified | — | Oral |
| Background | Nivolumab | Monoclonal antibody | — | — |
| Background | Vancomycin | Other / unclassified | — | Oral |